Cargando…
Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy
Mesenchymal stem cells (MSCs) can be derived from adult bone marrow, fat and several foetal tissues. In vitro, MSCs have the capacity to differentiate into multiple mesodermal and non-mesodermal cell lineages. Besides, MSCs possess immunosuppressive effects by modulating the immune function of the m...
Autores principales: | Liu, Meng, Han, Zhong Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865657/ https://www.ncbi.nlm.nih.gov/pubmed/18298656 http://dx.doi.org/10.1111/j.1582-4934.2008.00288.x |
Ejemplares similares
-
Mesenchymal stem cell therapy in type 2 diabetes mellitus
por: Zang, Li, et al.
Publicado: (2017) -
Safety of Mesenchymal Stem Cells for Clinical Application
por: Wang, Youwei, et al.
Publicado: (2012) -
Mesenchymal stem cells from biology to therapy
por: Kuntin, David, et al.
Publicado: (2021) -
Immunomodulation by Mesenchymal Stem Cells : A Potential Therapeutic Strategy for Type 1 Diabetes
por: Abdi, Reza, et al.
Publicado: (2008) -
Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
por: Jurewicz, Mollie, et al.
Publicado: (2010)